Charles, Chrys, Steve and Donna thank you for reading us, and wish all our Readers rest, refreshment, reflection and joy this festive season.
(We will be publishing on an occasional schedule through the holiday, but intend to do the same!)
Charles, Chrys, Steve and Donna thank you for reading us, and wish all our Readers rest, refreshment, reflection and joy this festive season.
(We will be publishing on an occasional schedule through the holiday, but intend to do the same!)
CTE research funded–and at a US theater near you Christmas Day
In the run-up to the holidays, our Readers may have missed another gift to those concerned with brain health–the National Institutes of Health (NIH) awarding of a major grant to fund research on chronic traumatic encephalopathy (CTE) to diagnose victims in vivo (while still alive). Awarded by NIH in conjunction with the National Institute of Neurological Disease and Stroke, the $16 million will go to researchers from Boston University, the Cleveland Clinic, Banner Alzheimer’s Institute (Arizona) and Brigham and Women’s Hospital in Boston. Leading the team is Robert Stern MD, Boston University professor and director of clinical research for BU’s Alzheimer’s disease and CTE centers, and a researcher we’ve followed since his June 2013 presentation at NYC’s German Center. According to a report in sports network ESPN’s ‘Outside the Lines’, the National Football League (NFL) refused to fund this research from their long term $30 million grant to the NIH due to Dr Stern’s alleged lack of objectivity; according to ESPN, a NIH official told ‘Outside the Lines’ that “the NFL’s $30 million gift was contingent on the league being able to veto decisions on projects that the money was funding.” Seemingly outside this research is another area of interest to Dr Stern–why some athletes have CTE, and others do not, as discussed in the May 2014 NYC MedTech ‘Brain Games’ presentation attended by this Editor. Medical-Net (BU release), New York Times
Sports CTE and brain injury is back on the front pages with the release of the film ‘Concussion’, starring Will Smith as foundational researcher Bennet Omalu MD, the then-Pittsburgh forensic pathologist who uncovered CTE after performing a detailed brain examination of Pittsburgh Steelers center Mike Webster, who died of a heart attack aged 50 in 2002. His 2005 case report with others from University of Pittsburgh in Neurosurgery was the kick-off (so to speak) and so enraged the NFL that they attempted to have it withdrawn from the journal. In this interview with Medscape EIC Eric Topol MD, Dr Omalu discusses (more…)
A fascinating and slightly cynical overview of Silicon Valley’s ideological view of health tech that will fix our ‘deeply flawed healthcare system’ and what is getting funded (or not) is in next month’s San Francisco magazine. It profiles the ‘citizen doctor’ founders of vital signs ‘tricorder’ Scanadu (Sam–who’s not often mentioned–and Walter De Brouwer), bacteria tracker uBiome, ‘personal data recorder’ and experience charter We Are Curious (founded by Linda Avey, a long-departed co-founder of 23andme) and touches on the Theranos debacle. While these stories are bracing and in the instance of the De Brouwers, courageous, the notion of ‘citizen science’ (defined as direct-to-consumer health data) and its companion, Dr Eric Topol’s patient-centered/controlled medicine, has its drawbacks, viewed through the slightly gimlety ‘digital doctor’ eye of UC San Francisco’s Dr Robert Wachter. “The overarching message—not just from Theranos but from other companies struggling to get a toehold—is that, ultimately, the laws of economic gravity hold. The companies will have to produce products that add real value, either to patients or to payers. If they don’t, the market—or the regulators—won’t treat them kindly.” Flatly, there aren’t enough Quantified Selfers right now to support these companies. And Mr Market is a hard master. 23andme is back in the good graces of the FDA after a two-year scuffle and back doing direct response TV here in the US. Scanadu’s two products, Vitals (formerly Scout) and Urine are still not through the long slog of FDA clearance. The jury’s out on Theranos. And all these companies, including ‘unicorn’ Theranos, are bleeding cash and nowhere near turning a profit. ModernLuxury. Hat tip to Dr Topol via Twitter, who had a patient-centered conversation with Dr Wachter that we covered back in September. Another recent podcast with Dr Wachter is here (Community Health Center radio).
Update: ‘Citizen science’ is nothing new, as revealed by the Science Museum (London)–it’s over 300 years old. While it entered the OED in 2014, ‘in 1715, Edmund Halley used Philosophical Transactions to ask colleagues to help him observe a total solar eclipse, prompting observers from all over the country to respond.’ Other examples are from Benjamin Robins in the same publication in 1749 on fireworks, Charles Darwin and evolution, to the present day. The difference is the flow–similar to what we now call crowdsourcing versus the individual using the data to affect their care.
Update. During CES, Parks Associates will hosting their 7th annual CONNECTIONS Summit on 6-7 January (Wednesday – Thursday). The most health tech related session is ‘Wearables: Healthcare, IoT, and Smart Home Use Cases’ on Wednesday 10:30am-11:45am, with a panel including executives from Honeywell Life Care, Care Innovations, Qualcomm, Independa, IFTTT and Lumo Body Tech, hosted by director Harry Wang of Parks whom this Editor counts as a Grizzled Pioneer, Research Division. Separate registration required. Information and full agenda here.
To our Readers: Are you attending CES? Interested in contributing some insights? Contact Editor Donna.
Insurer Aviva’s latest Health Check study headlined the following findings about UK adults’ growing preference for digital health options, including a growth in acceptance of wearable monitors:
Aviva has an interest in digital health through its recently established customer partnership with babylon‘s UK-based telemedicine app [TTA 26 May]. The study was conducted by ICM Research for Aviva UK Health in August 2015. Respondents were invited from ICM’s online panel and 2,004 interviews were conducted amongst a nationally representative sample of the UK adult population.
The full study is available here to our Readers. Aviva release.
ReWalk has identified 45 paralyzed veterans who qualify, (more…)
Rock Health published yesterday their 2015 annual Digital Health Funding report, and perhaps it is good news that 2015 activity maintained the blazing 2014 total at $4.3 bn. Still, it represents a compound annual growth (CAGR) from 2011-2015 of 30 percent.
Consumer digital health is thriving, with healthcare consumer engagement, personal health tools and tracking accounting for 23 percent of overall funding. Two of the six largest deals were won by consumer-driven genetic companies, 23andMe and Helix.
The one new record was that there were 278 deals across 248 companies, with an record-breaking average deal size of $15.6m. What continued is that the vast majority of funding deals (70 percent) were Series B and below, but C and C+ deals increased slightly. It was also a big year for exits. M&A activity nearly doubled in volume with 180 deals and $6B in disclosed activity. Their index comprising shares of publicly traded digital health companies was off over 5 percent with two of this year’s IPOs trading lower than their opening prices.
According to the Rock Health newsletter, early-funded companies had a few zombies among them. Rock Health looked at companies up to five years ago, and found that 11 percent they classified as either dead or “zombies” (which have not raised a round in 3+ years). “Most likely to die? A disproportionate number of these zombie companies are in the care coordination, EHR, or clinical workflow space.”
The web page with a link to the full study is here. Unfortunately, the download is not free, but $99.
Biltmore Hotel, Coral Gables (Miami), Florida, 7am-6pm
Daydreaming of a post-holiday warm weather break? The HealthIMPACT events are relatively small conferences that typically cover a lot of connected health ground in a few hours. The fast paced format combines single presenters and panels into primarily 30 minute sessions (some as short as 15 minutes). Presenters are from a mix of backgrounds and come from health systems, HIT, academia and community health. This Editor has attended two events in NYC and has been impressed (and that’s not easy) with the presentations, the breaks, the attendees and the venues. Information and registration.
Other upcoming HealthIMPACT events: Southwest 24 March (Marriott Medical Center, Houston), East 17 May (Westin Times Square, NYC), West 9 June (Anaheim)
This year, on the 10th Anniversary of Telehealth and Telecare Aware, we invited industry leaders to reflect on the past ten years and, if they wish, to speculate about the next ten. We are pleased to publish the following item from Steve Sadler, who has been Chief Technology Officer for the Tunstall Group since 1996.
My reflections on the last decade describe a laying of the foundations for ‘connected care’.
The decade has seen continued and huge pressures on health, care and housing, driven by our living longer and with increasing prevalence of long-term conditions.
We have also seen major disruptions to economies worldwide, affecting their ability to continue funding traditional models of care. The resulting public sector budget constraints are daunting, pushing us to explore technology-enabled transformation of services.
At the same time we are experiencing helpful developments in technology, prompting questions as to how we can do more with IP-connectivity, health apps, internet of things, cloud and big data analytics, to help us to shape solutions that bridge the gap between our needs and our resources.
An Exciting Beginning: So what was so special about the last 10 years? (more…)
The Telehealth Innovation and Improvement Act (Senate Bill 2343), a bipartisan bill to expand Medicare coverage of rural telehealth, was proposed last week by Senators Cory Gardner of Colorado and Gary Peters of Michigan. It would authorize Health and Human Services (HHS) to test new telehealth programs through the Center for Medicare and Medicaid Innovation. CMMI would then evaluate new telehealth models on cost, effectiveness and care improvement. Senator Gardner’s intent is to permanently expand rural telehealth. The bill has moved to the Finance committee. Another Senate bill may be proposed before the holiday break by Hawaii Senator Brian Schatz to integrate telemedicine technology into alternative payment programs including Medicaid Advantage, a service of great utility in his state where 70 percent of the population is on one island, Oahu, and about 30 percent is scattered over four other islands. iHealthBeat, mHealthIntelligence.
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/12/alp-mountains-peaks-in-winter.jpg” thumb_width=”150″ /]An app developer and a healthcare/digital health innovation lab get into the certification game. Can they fly over the treacherous peaks this time? Social Wellth made good on their promise (or threat?) to get into the app vetting business this past week through announcing a partnership with Columbia University-based HITLAB at the HITLAB Summit this week to develop a certification organization known as Xcertia. Last year, Social Wellth acquired the remains of Happtique from GNYHA Ventures [TTA 12 Dec 14]. The Xcertia principles center around privacy, security, operability and content–as Happtique’s did. The intent is to not only develop a program to certify apps based on established standards, but also form a Signature Steering Committee to ensure they maintain “their definitive set of criteria for evaluating mobile health apps.” MedCityNews, release
Possible conflict of interest. It all sounds positive, but the head of Xcertia, David Vinson, is also the CEO of Social Wellth, which despite its nonprofit-ish name makes its living by developing consumer apps and “dashboards” for insurance companies, a task grandly called (from their press release) “the curation of digital health experiences by leveraging mobile health technologies that allow for integration and aggregation of all digital assets.” Social Wellth also makes quite a bit of hay on its website about app curation for its clients. (more…)
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/12/08ELDERBOT1-master675.jpg” thumb_width=”150″ /]A Saturday Robot Fix! Short article in yesterday’s NY Times about development of tiny household drones to fetch medications and do other simple tasks around the house (like cleaning). These ‘Bibiddi Bobbidi Bots’ are under development at the University of Illinois. This Editor will take several to go clean. But do they do laundry? I’d rather take the new iteration of a 4′ Robby the Robot under development in Seattle by an ex-Microsofter who founded Hoaloha Robotics. Practical? Perhaps not, says Laurie Orlov of Age in Place Technology, who’s been up and down a few hype curves. And will it help older people stay connected, even though help around the house is always appreciated? The withering comment on the Jibo robot from a 91 year old at the end of the article does put a damper on it. Still, Robby could make me a dress of sapphires any old time (as did his namesake in Forbidden Planet). As Aging Population Grows, So Do Robotic Health Aides
Our Readers are likely well aware that older medical devices may present a Hacker’s Holiday, but putting a very fine point on it was Kevin Fu, associate professor of electrical engineering and computer science at University of Michigan, speaking at a Healthcare IT News healthcare cybersecurity forum this week in Boston. Mr Fu pointed out that many hospitals are actively using old devices and old PC systems; one local hospital had 600 supposedly unpatched Windows XP (!) boxes deployed. Older medical devices were not designed with security in mind, which he likens to basic sanitation:
“If you’re using this old software, these old operating systems, you’re vulnerable to all that malware – that garden-variety malware – that has been out in the wild for more than 10 years.” and “This is not rocket science; this is basic hygiene. This is forgetting to wash your hands before going into the operating room. Here we have medical devices where, if malware gets through the perimeter, there is very little defense.”
The press has been concentrating on the big breaches and external hacking (they do make good copy–Ed.), and we’ve expended a lot of air on things like the EHR Wars, but the real threats are more mundane, as Ponemon and others in the field have warned for years. Software updates and infected USB flash drives can spread malware. A vendor can be a regular Typhoid Mary unintentionally corrupting systems and devices down the line. (more…)
20-21 January 2016, FDA White Oak Campus, Silver Spring Maryland
Attend this free and public two-day workshop hosted by FDA on cybersecurity and medical devices highlighting “past collaborative efforts, increase awareness of existing maturity models (i.e. frameworks leveraged for benchmarking an organization’s processes) which are used to evaluate cybersecurity status, standards, and tools in development, and to engage the multi-stakeholder community in focused discussions on unresolved gaps and challenges that have hampered progress in advancing medical device cybersecurity.” Registration required (information and form here), but there is also a webcast (link available after 13 Jan) if you cannot make it to FDA.
Update: Tart take from seasoned Aging Tech business observer Laurie Orlov on Lively’s rise and fall, with additional history. Her POV is that as attractive as Lively’s concept was, its business strategy should give pause to the Silicon Valley investor and entrepreneur crowd thinking this is just another kind of direct-to-consumer hardware-service sell, the long payout of any tech in this field and the opposed short time frame of VCs. It’s also not like there haven’t been a few predecessors fallen on the field, either. Aging in place tech firm Lively is out of business – what can we learn?
One of the most logical places for telehealth, remote care management (RCM) and transitional/chronic condition management (TCM/CCM) is with home health providers and post-acute care, yet perennially it has been on the ‘maybe next year’ list for most telehealth providers. That ‘next year’ may be getting a little closer with the news that Intel-GE Care Innovations has inked a multi-year deal (no pilot-itis here) with major (~400 facilities) home health provider Amedisys using their PC/tablet-based Health Harmony platform.
The initial focus is an ambitious one: reducing hospitalizations and ER/ED visits among patients with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, depression as well as patients who have two or more of these conditions (co-morbidities). The most interesting to this Editor is the parenthetical mention of analyzing ADLs (activities of daily living) with clinical data. Does this imply the engagement of their venerable ADL monitor QuietCare? (It’s something the founding company worked on circa 2006 while this Editor was there; one would think the analytics have advanced since then.) Another aspect is that Care Innovations will manage Amedisys’ complete RCM program from recruiting to logistics, data analytics and application integration services. Business Wire
What this means: Telehealth (and telecare) companies are now increasingly obliged in these big wins to provide a plethora of additional related services. Health care providers demand services beyond the monitoring technology. They want the turnkey package, from nurse evaluations, care coordination/management, to analytics and logistics.This ‘service creep’ implies alliances and mergers to add on to technological monitoring capabilities–and beaucoup financing. (more…)
Most Recent Comments